<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Transl Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Transl Psychiatry</journal-id>
<journal-title-group>
<journal-title>Translational Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="epub">2158-3188</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30446648</article-id>
<article-id pub-id-type="pmc">5802468</article-id>
<article-id pub-id-type="publisher-id">7</article-id>
<article-id pub-id-type="doi">10.1038/s41398-017-0007-4</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Pleiotropic effects of schizophrenia-associated genetic variants in neuron firing and cardiac pacemaking revealed by computational modeling</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7082-2507</contrib-id>
<name>
<surname>Mäki-Marttunen</surname>
<given-names>Tuomo</given-names>
</name>
<address>
<phone>+4745462103</phone>
<email>tuomomm@uio.no</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lines</surname>
<given-names>Glenn T.</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Edwards</surname>
<given-names>Andrew G.</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tveito</surname>
<given-names>Aslak</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dale</surname>
<given-names>Anders M.</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Einevoll</surname>
<given-names>Gaute T.</given-names>
</name>
<xref ref-type="aff" rid="Aff6">6</xref>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4461-3568</contrib-id>
<name>
<surname>Andreassen</surname>
<given-names>Ole A.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8921</institution-id><institution-id institution-id-type="GRID">grid.5510.1</institution-id><institution>NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, </institution><institution>University of Oslo, </institution></institution-wrap>Oslo, Norway </aff>
<aff id="Aff2"><label>2</label>Simula Research Laboratory and Center for Cardiological Innovation, Oslo, Norway </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2107 4242</institution-id><institution-id institution-id-type="GRID">grid.266100.3</institution-id><institution>Multimodal Imaging Laboratory, </institution><institution>UC San Diego, </institution></institution-wrap>La Jolla, CA USA </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2107 4242</institution-id><institution-id institution-id-type="GRID">grid.266100.3</institution-id><institution>Department of Neurosciences, </institution><institution>University of California San Diego, </institution></institution-wrap>La Jolla, CA USA </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2107 4242</institution-id><institution-id institution-id-type="GRID">grid.266100.3</institution-id><institution>Department of Radiology, </institution><institution>University of California, San Diego, </institution></institution-wrap>La Jolla, CA USA </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0607 975X</institution-id><institution-id institution-id-type="GRID">grid.19477.3c</institution-id><institution>Department of Mathematical Sciences and Technology, </institution><institution>Norwegian University of Life Sciences, </institution></institution-wrap>Ås, Norway </aff>
<aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8921</institution-id><institution-id institution-id-type="GRID">grid.5510.1</institution-id><institution>Department of Physics, </institution><institution>University of Oslo, </institution></institution-wrap>Oslo, Norway </aff>
<aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0389 8485</institution-id><institution-id institution-id-type="GRID">grid.55325.34</institution-id><institution>Division of Mental Health and Addiction, </institution><institution>Oslo University Hospital, </institution></institution-wrap>Oslo, Norway </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>17</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>17</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<month>11</month>
<year>2017</year>
</pub-date>
<volume>7</volume>
<elocation-id>5</elocation-id>
<history>
<date date-type="received">
<day>6</day>
<month>3</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>7</day>
<month>7</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>7</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2017</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Schizophrenia patients have an increased risk of cardiac dysfunction. A possible factor underlying this comorbidity are the common variants in the large set of genes that have recently been discovered in genome-wide association studies (GWASs) as risk genes of schizophrenia. Many of these genes control the cell electrogenesis and calcium homeostasis. We applied biophysically detailed models of layer V pyramidal cells and sinoatrial node cells to study the contribution of schizophrenia-associated genes on cellular excitability. By including data from functional genomics literature to simulate the effects of common variants of these genes, we showed that variants of voltage-gated Na<sup>+</sup> channel or hyperpolarization-activated cation channel-encoding genes cause qualitatively similar effects on layer V pyramidal cell and sinoatrial node cell excitability. By contrast, variants of Ca<sup>2+</sup> channel or transporter-encoding genes mostly have opposite effects on cellular excitability in the two cell types. We also show that the variants may crucially affect the propagation of the cardiac action potential in the sinus node. These results may help explain some of the cardiac comorbidity in schizophrenia, and may facilitate generation of effective antipsychotic medications without cardiac side-effects such as arrhythmia.</p>
</abstract>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p id="Par2">Schizophrenia (SCZ) is a heritable mental disorder with a high burden of morbidity and large social impacts<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. A recent genome-wide association study (GWAS) has identified more than a hundred genetic loci exceeding genome-wide significance<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. The loci implicate genes that encode numerous ion channel subtypes and calcium transporters and are major contributors to the functions of cells in not only brain but also organs outside the central nervous system, such as heart. Evidence for increased cardiac dysfunction in SCZ patients are shown by meta-studies that reported a 2.5–3-fold increase in mortality rates<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref></sup>. Approximately 40% of the excess deaths are caused by accidents and suicides, while the remaining 60% are natural<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>—and largely due to cardiovascular disease<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Some of these excess deaths are linked to the increased risk of sudden cardiac death conveyed by long-term use of antipsychotic drugs<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>, many of which are known to have side-effects related to arrhythmia, including prolongation of QT interval<sup><xref ref-type="bibr" rid="CR8">8</xref></sup> and torsades de pointes<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. In parallel to these observations, GWASs of cardiac phenotypes, such as electrocardiographic (ECG) measures, highlight a set of genes that overlaps with the one discovered in GWASs of SCZ<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup>. Nevertheless, both the genetic and mechanistic connections between cardiac and neural phenotypes in SCZ patients remain poorly understood. Here, we attempt to combine our recently developed genetic approaches with biophysical models of well-characterized cardiac and neuronal cell types to provide general mechanistic links between neural and cardiac tissue for SCZ-associated variants.</p>
<p id="Par3">It is of key relevance to know if there is an inherent, genetic risk in addition to the external, drug-induced risks in the treatment of SCZ that may underlie the comorbidity between cardiac disease and SCZ—the SCZ-associated single-nucleotide polymorphisms (SNPs) might, however, as well be protective against cardiac disease. The effects of primarily brain disorder-related SNPs on cardiac phenotypes is a largely unexplored area, while there are a few examples of the opposite: SNPs that were first identified by a cardiac disease and then found to convey a risk of brain dysfunction, such as seizures<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup>. The cellular homogeneity in the heart, in contrast to the heterogeneity in both structure and function of the brain, is an important aid in uncovering cross-tissue functional genetics in both approaches.</p>
<p id="Par4">SCZ is associated with genes affecting transmembrane currents of all major cationic species, Na<sup>+</sup>, K<sup>+</sup>, and Ca<sup>2+</sup> (ref. <xref ref-type="bibr" rid="CR2">2</xref>). In addition, some of the SCZ-linked genes are involved in regulation of intracellular Ca<sup>2+</sup> dynamics<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>, which importantly modulate cellular excitability in both the heart and brain, via a range of Ca<sup>2+</sup>-sensitive plasma membrane current carriers. The rise of biophysical modeling of neurons<sup><xref ref-type="bibr" rid="CR14">14</xref></sup> and cardiac pacemaker cells<sup><xref ref-type="bibr" rid="CR15">15</xref></sup> provide a solid basis for analyzing this intrinsic excitability as a coordinated interplay of ion channels and ion transporters. In addition, there is an increasing amount of <italic>in vitro</italic> data on the effect of genetic variations on such ion channel or calcium transporter functions, and much of these data can be implemented in the biophysical models. This opens the door for a mechanistic analysis of SCZ-related genes<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>, mapping the functional genomics data to predictions of cellular function and dysfunction both in neural and cardiac tissue.</p>
<p id="Par5">In this work, we use computational modeling to study the contribution of SCZ-associated genes to cardiac and neuronal excitability. We focus our analyses on two well-studied cell types that are central to cortical information processing and cardiac pacemaking, namely, layer V pyramidal cells (L5PCs) in the cortex and sinoatrial node cells (SANCs) in the myocardium. The apical tuft of an L5PC integrates non-local synaptic inputs, and is considered a biological substrate for cortical associations providing high-level context for low-level (e.g., sensory) inputs that arrive at the perisomatic compartments<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. Therefore, the ability of L5PC to integrate the apical and perisomatic inputs has been proposed as one of the mechanisms that could be impaired in hallucinating patients<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. The SANCs, in turn, have a key role in controlling heart rate as the primary pacemakers of the mammalian heart. While SANCs derive from cardiac lineage and are, therefore, regarded as a specialized form of myocardium, their morphology, electrophysiology, and ion-channel expression profiles are the most neuron-like of any studied cardiac muscle cell type. As such, they represent a population of cardiac cells that may be most apt to display functional alterations as a result of SCZ-associated variants. We apply two recent L5PC models<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR19">19</xref></sup> and two recent SANC models<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup> to argue for the generality of our findings.</p>
<p id="Par6">We show that subtle SNP-like variants of ion-channel and calcium-transporter-encoding genes cause notable effects in intrinsic excitability of both neurons and heart cells. Our approach is limited by the data concerning the functional effects of the SCZ-related common genetic variants. To overcome this limitation, we concentrate on a set of <italic>in vitro</italic>-observed effects of more extreme genetic variations, as described previously<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. A key assumption of our approach is that the effects of SNP variants can be represented as downscaled versions of the more extreme variants, and that the emergence of disease phenotypes results from the combined effect of a large number of subtle SNP effects<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR23">23</xref></sup>. Our results contribute to explaining some of the cardiac comorbidity in schizophrenia, and could form the basis for development of antipsychotic medications that are free from cardiac side-effects.</p>
</sec>
<sec id="Sec2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="Sec3">
<title>Models of neurons and cardiac pacemaker cells</title>
<p id="Par7">We apply two multicompartmental L5PC models, “Hay”<sup><xref ref-type="bibr" rid="CR18">18</xref></sup> and “Almog”<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> model, and two single-compartment SANC models, “Kharche”<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> and “Severi”<sup><xref ref-type="bibr" rid="CR21">21</xref></sup> model. These models include Hodgkin-Huxley type description for channel activation and inactivation, and hence, changes related to certain ion-channel-encoding gene variants that have been observed in experiments can be directly attributed to a change of one or more parameters of these models. The Hay and Almog neuron models are based on electrophysiological recordings and cell stainings from rat neocortical slices, while the Kharche and Severi models are based on mouse and rabbit data, respectively. For details on the models, see <xref ref-type="media" rid="MOESM1">Supplementary information</xref>.</p>
<p id="Par8">Both L5PC models are simulated using NEURON software and Python interface using adaptive time-step integration. The 0-dimensional (point-cell) and 1-dimensional (chain of cells) SANC models are simulated using MATLAB, and the numerical integration is carried out using the variable time-step, stiff differential equation solver ode15s (0-dimensional) or the finite difference method with 0.01 ms time step (1-dimensional). For the 2-dimensional problem, we use the monodomain model<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>, which is simulated using the finite element method solver FEniCS<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. For details on the spatial distribution of parameters in the 2D simulations, see ref.<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. Scripts for running L5PC and 0D SANC simulations are publicly available (<ext-link ext-link-type="uri" xlink:href="https://senselab.med.yale.edu/ModelDB/showModel.cshtml?model=187615">https://senselab.med.yale.edu/ModelDB/showModel.cshtml?model=187615</ext-link>).</p>
</sec>
<sec id="Sec4">
<title>Genes included in the study</title>
<p id="Par9">We chose the set of SCZ-associated genes as follows: We used the SNP-wise <italic>p</italic>-value data of ref. <xref ref-type="bibr" rid="CR2">2</xref>, and for each gene of interest, determined the minimum <italic>p</italic>-value among those SNPs that were located in the considered gene. We performed this operation for all genes encoding either subunits of voltage-gated Ca<sup>2+</sup>, K<sup>+</sup>, or Na<sup>+</sup> channels, subunits of an SK, leak, or hyperpolarization-activated cyclic nucleotide-gated (HCN) channel, or Ca<sup>2+</sup>-transporting ATPases. Several of these genes were found to contain SNPs bearing a high risk of SCZ (<italic>p</italic>-value smaller than 3 × 10<sup><italic>−</italic>8</sup> in the data of ref. <xref ref-type="bibr" rid="CR2">2</xref>, namely, <italic>CACNA1C</italic>, <italic>CACNB2</italic>, <italic>CACNA1I</italic>, <italic>ATP2A2</italic>, and <italic>HCN1</italic>. Using a more relaxed threshold (<italic>p</italic>-value smaller than 3 × 10<sup><italic>−</italic>5</sup>) extended this set by the genes <italic>CACNA1D</italic>, <italic>SCN1A</italic>, <italic>SCN9A</italic>, <italic>KCNN3</italic>, <italic>KCNS3</italic>, <italic>KCNB1</italic>, <italic>KCNMA1</italic>, and <italic>ATP2B2</italic>. This selection was identical to that in our previous work<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. In this work, however, we concentrate on the genes that are likely to play a role in both L5PCs and SANCs: these are <italic>CACNA1C</italic>, <italic>CACNB2</italic>, <italic>CACNA1I</italic>, <italic>ATP2A2</italic>, <italic>HCN1</italic>, <italic>CACNA1D</italic>, and <italic>SCN1A</italic>.</p>
<p id="Par10">It should be noted that we used the SNPs reported in ref. <xref ref-type="bibr" rid="CR2">2</xref> only to name the above SCZ-related genes, and due to lack of data on their electrophysiological effects, we could not include the actual SCZ-related SNPs. In fact, only 14 of 527 SNPs that had a <italic>p</italic>-value smaller than 3 × 10<sup><italic>−</italic>5</sup> were highlighted in online databases (PubMed or SNPedia), and none of these 14 SNPs have yet been studied functionally, either in native or in heterologous cells. Therefore, we searched in PubMed for functional genomic studies reporting the effects of <italic>any</italic> genetic variant of the above genes, as described below. We only included studies that reported electrophysiological or intracellular Ca<sup>2+</sup> imaging data, but we accepted studies performed using all tissue types. Nevertheless, most of the included studies were carried out in embryonic kidney cells.</p>
</sec>
<sec id="Sec5">
<title>Gene variants and their downscaled versions</title>
<p id="Par11">Table <xref ref-type="table" rid="Tab1">1</xref> lists all studies<sup><xref ref-type="bibr" rid="CR27">27</xref>–<xref ref-type="bibr" rid="CR56">56</xref></sup> that we found where the effects of a variant were measured in a way that could be directly implemented as a parameter change in our models. A more detailed version of this table is given in <xref ref-type="media" rid="MOESM1">Supplementary information</xref>, Supplementary Table <xref ref-type="media" rid="MOESM1">S1</xref>. As SCZ is a polygenic disorder, it has been proposed that the disorder will not be induced by any of the SCZ-related SNPs alone, but only when sufficiently many of them are represented. Furthermore, as most of these SNPs are common variants<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>, it is likely that none of them alone can cause radical cardiac dysfunction—however, their combination could underlie the risk of heart disease that has been observed in SCZ patients. This paradigm was used in this study in a similar fashion as in ref. <xref ref-type="bibr" rid="CR16">16</xref>. If the variants described in Supplementary Table <xref ref-type="media" rid="MOESM1">S1</xref> altered the neural response or cardiac pacemaking too dramatically (see conditions A1–A5 and B1–B2 in <xref ref-type="media" rid="MOESM1">Supplementary information</xref>), the changes in the model parameters were brought closer to zero (all in proportion) until a point <italic>c</italic> ∈[0, 1] where one or more of the scaling conditions were first violated. This downscaling was performed so that those parameters that may receive both negative and positive values were scaled linearly (∆ → <italic>c</italic>∆, where ∆ denotes the original increment to the underlying parameter as obtained from the literature data) while the parameters that receive only positive values were scaled on the logarithmic scale (Γ → Γ<sup><italic>c</italic></sup>, where Γ denotes the original factor of the underlying model parameter). In other words, the differences in offset and reverse potentials (<italic>V</italic>
<sub>offm</sub>, <italic>V</italic>
<sub>offh</sub>) between control and variant neuron were expressed as an additive term ( ± <italic>x</italic> mV), and this term <italic>x</italic> was multiplied by a parameter <italic>c</italic> in the downscaling procedure. By contrast, the differences in all the other model parameters (<italic>V</italic>
<sub>slo</sub>, <italic>τ</italic>, <italic>P</italic>
<sub>up</sub>, <italic>γ</italic>) between control and variant neuron were expressed as a multiplication (× <italic>x</italic>), where the downscaling caused this factor <italic>x</italic> to be exponentiated by the same parameter <italic>c</italic>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Table of the genetic variants used in this study</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Gene</th><th>Refs.</th><th>Type of variant</th><th>Cell type</th></tr></thead><tbody><tr><td>
<italic>CACNA1C</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>
</td><td>L429T, L434T, S435T, S435A, S435P</td><td>TSA201</td></tr><tr><td>
<italic>CACNA1C</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>
</td><td>L779T, I781T, I781P</td><td>TSA201</td></tr><tr><td>
<italic>CACNA1C</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>
</td><td>G432X, A780X, G1193X, A1503X</td><td>TSA201</td></tr><tr><td>
<italic>CACNA1C</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>
</td><td>I781X, C769P, G770P, N771P, I773P, F778P, L779P, A780P, A782P, V783P</td><td>TSA201</td></tr><tr><td>
<italic>CACNA1C</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>
</td><td>I781T, N785A, N785G, N785L</td><td>TSA201</td></tr><tr><td>
<italic>CACNA1C</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>
</td><td>Splice variants a1C77-A, -B, -C, and -D</td><td>TSA201</td></tr><tr><td>
<italic>CACNA1D</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup>
</td><td>Splice variant 42A</td><td>TSA201/HEK293</td></tr><tr><td>
<italic>CACNA1D</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup>
</td><td>Splice variant 43S</td><td>TSA201/HEK293</td></tr><tr><td>
<italic>CACNA1D</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>
</td><td>Homozygous knockout</td><td>AV node cells / chromaffin cells</td></tr><tr><td>
<italic>CACNA1D</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>
</td><td>A749G</td><td>TSA201</td></tr><tr><td>
<italic>CACNA1D</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>
</td><td>V259D, I750M, P1336R</td><td>TSA201</td></tr><tr><td>
<italic>CACNA1D</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>
</td><td>rCav1.3scg variant and related mutants</td><td>TSA201</td></tr><tr><td>
<italic>CACNB2</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>
</td><td>T11I</td><td>TSA201</td></tr><tr><td>
<italic>CACNB2</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>
</td><td>A1B2 vs A1 alone</td><td>HEK293</td></tr><tr><td>
<italic>CACNB2</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>
</td><td>Splice variants N1, N3, N4, N5</td><td>HEK293</td></tr><tr><td>
<italic>CACNB2</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>
</td><td>D601E</td><td>TSA201</td></tr><tr><td>
<italic>CACNA1I</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>
</td><td>Alternative splicing of exons 9 and 33</td><td>HEK293</td></tr><tr><td>
<italic>CACNA1I</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>
</td><td>Truncated cDNAs L4, L6, and L9</td><td>HEK293</td></tr><tr><td>
<italic>ATP2A2</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR45">45</xref>,<xref ref-type="bibr" rid="CR46">46</xref></sup>
</td><td>Heterozygous null mutation</td><td>Myocytes, embryonic stem cells</td></tr><tr><td>
<italic>ATP2A2</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>
</td><td>Dairier’s disease related mutants</td><td>HEK293</td></tr><tr><td>
<italic>ATP2A2</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>
</td><td>Dairier’s disease related mutants</td><td>HEK293</td></tr><tr><td>
<italic>SCN1A</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>
</td><td>Q1489K</td><td>Cultured neocortical cell</td></tr><tr><td>
<italic>SCN1A</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>
</td><td>L1649Q</td><td>TSA201</td></tr><tr><td>
<italic>SCN1A</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>
</td><td>R859H</td><td>TSA201</td></tr><tr><td>
<italic>SCN1A</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>
</td><td>R865G</td><td>TSA201</td></tr><tr><td>
<italic>SCN1A</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>
</td><td>T1174S</td><td>TSA201</td></tr><tr><td>
<italic>SCN1A</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>
</td><td>M145T</td><td>TSA201</td></tr><tr><td>
<italic>HCN1</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>
</td><td>D135W, D135H, D135N</td><td>HEK293</td></tr><tr><td>
<italic>HCN1</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>
</td><td>E229A, K230A, G231A, M232A, D233A, S234A, E235G, V236A, Y237A, EVY235-237DDD</td><td>Oocytes</td></tr><tr><td>
<italic>HCN1</italic>
</td><td>
<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>
</td><td>WAG-HCN1</td><td>Oocytes</td></tr></tbody></table><table-wrap-foot><p>For more details, see Supplementary Table <xref ref-type="media" rid="MOESM1">S1</xref> and Supplementary Table <xref ref-type="media" rid="MOESM1">S2</xref>
</p></table-wrap-foot></table-wrap>
</p>
<p id="Par12">The scaling conditions were designed such that the variant L5PCs and SANCs retain their baseline firing (L5PC) and pacemaking (SANC) behavior: Conditions A1–A3 require that the variant L5PCs respond with the same numbers of spikes to certain stimuli as the control L5PCs, while conditions A4 and B1 require that the firing (L5PC) or pacemaking (SANC) frequency is not radically changed, and conditions A5 and B2 make sure that the shape of the action potentials is not too different from that of the control cell.</p>
<p id="Par13">The downscaling was done separately for each applied model; see Supplementary Table <xref ref-type="media" rid="MOESM1">S2</xref> for the scaling parameters <italic>c</italic> obtained for each variant and each model. Supplementary Fig. <xref ref-type="media" rid="MOESM1">S1</xref> illustrates the distribution of the variant effects of a single gene, <italic>SCN1A</italic>, on activation and inactivation voltage-dependency parameters in the Hay model, and shows that the variants span a large array of possible alterations of ion-channel dynamics. This is true also for the variants of other ion-channel-encoding genes (data not shown).</p>
<p id="Par14">In the following, we present simulation data from the cells implemented with variants of different magnitude and direction, parametrized by variable <italic>ϵ</italic>. This parametrization is done so that the final effect sizes of the variants are the values of Supplementary Table <xref ref-type="media" rid="MOESM1">S2</xref> multiplied or exponentiated by <italic>ϵc</italic> (see <xref ref-type="media" rid="MOESM1">Supplementary information</xref>). Variants with <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }}\frac{1}{2}$$\end{document}</tex-math><mml:math id="M2"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq1.gif"></inline-graphic></alternatives></inline-formula> and <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }}\frac{1}{4}$$\end{document}</tex-math><mml:math id="M4"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq2.gif"></inline-graphic></alternatives></inline-formula> mean that the variant effects on model parameters are half or quarter, respectively, of those of the threshold variants—these variants are, therefore, confirmed to obey the above-mentioned scaling conditions. In addition, we consider the variants <inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }} - \frac{1}{2}$$\end{document}</tex-math><mml:math id="M6"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq3.gif"></inline-graphic></alternatives></inline-formula> and <inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }} - \frac{1}{4}$$\end{document}</tex-math><mml:math id="M8"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq4.gif"></inline-graphic></alternatives></inline-formula>, which represent parameter changes that are opposite to those of <inline-formula id="IEq5"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }}\frac{1}{2}$$\end{document}</tex-math><mml:math id="M10"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq5.gif"></inline-graphic></alternatives></inline-formula> and <inline-formula id="IEq6"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }}\frac{1}{4}$$\end{document}</tex-math><mml:math id="M12"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq6.gif"></inline-graphic></alternatives></inline-formula> variants.</p>
</sec>
</sec>
<sec id="Sec6" sec-type="results">
<title>Results</title>
<sec id="Sec7">
<title>Pleiotropic effects of Na<sup>+</sup> and non-selective ion channel gene variants are analogous</title>
<p id="Par15">To characterize the joint implications of SCZ-related genes on neuron excitability and cardiac pacemaking, we started by analyzing the effects of the downscaled versions of genetic variants of Na<sup>+</sup> and hyperpolarization-activated cyclic nucleotide-gated (HCN) channel-encoding genes, namely, <italic>SCN1A</italic> and <italic>HCN1</italic>. Fig. <xref ref-type="fig" rid="Fig1">1a</xref> shows the time course of the membrane potential for several versions of a <italic>SCN1A</italic> variant, predicted by both L5PC models (when a somatic DC stimulus is applied) and both SANC models (at steady pacemaking). Moreover, Fig. <xref ref-type="fig" rid="Fig1">1b</xref> shows the f–I curves, where the firing frequency is plotted against the amplitude of the injected current, and threshold currents for inducing a spike in an L5PC for several <italic>SCN1A</italic> and <italic>HCN1</italic> variants, and the changes these variants cause to the pacemaking frequencies in SANCs.<fig id="Fig1"><label>Fig. 1</label><caption><title>Effects of Na<sup>+</sup> and HCN channel gene variants on L5PC and SANC excitability are qualitatively similar</title><p>
<bold>a</bold> The membrane-potential time courses of the modeled cells in control cells and Na<sup>+</sup> channel variant cells. The L5PCs are stimulated with a somatic DC of amplitude 1.0 nA (Hay model, top panel) or 0.8 nA (Almog model, second from top) to induce stable spiking, while the SANCs rhythmically fire cardiac action potentials without any external stimulus (Kharche model third from top, Severi model on the bottom panel). Different colors represent different scalings of the same variant, parametrized by variable <inline-formula id="IEq7"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon$$\end{document}</tex-math><mml:math id="M14"><mml:mi>ϵ</mml:mi></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq7.gif"></inline-graphic></alternatives></inline-formula>. Variants with <inline-formula id="IEq8"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }}\frac{1}{2}$$\end{document}</tex-math><mml:math id="M16"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq8.gif"></inline-graphic></alternatives></inline-formula> and <inline-formula id="IEq9"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }}\frac{1}{4}$$\end{document}</tex-math><mml:math id="M18"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq9.gif"></inline-graphic></alternatives></inline-formula> mean that the variant effects on model parameters are half or quarter, respectively, of those of the threshold variants (see threshold parameters <italic>c</italic> in Supplementary Table <xref ref-type="media" rid="MOESM1">S2</xref>)—these variants are, therefore, confirmed to obey the above-mentioned scaling conditions. In addition, we consider the variants <inline-formula id="IEq10"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }} - \frac{1}{2}$$\end{document}</tex-math><mml:math id="M20"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq10.gif"></inline-graphic></alternatives></inline-formula> and <inline-formula id="IEq11"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }} - \frac{1}{4}$$\end{document}</tex-math><mml:math id="M22"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq11.gif"></inline-graphic></alternatives></inline-formula>, which represent parameter changes that are opposite to those of <inline-formula id="IEq12"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }}\frac{1}{2}$$\end{document}</tex-math><mml:math id="M24"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq12.gif"></inline-graphic></alternatives></inline-formula> and <inline-formula id="IEq13"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }}\frac{1}{4}$$\end{document}</tex-math><mml:math id="M26"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq13.gif"></inline-graphic></alternatives></inline-formula> variants. Blue: control, magenta:<inline-formula id="IEq14"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }}\frac{1}{2}$$\end{document}</tex-math><mml:math id="M28"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq14.gif"></inline-graphic></alternatives></inline-formula>, gray: <inline-formula id="IEq15"><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }}\frac{1}{4}$$\end{document}</tex-math><mml:math id="M30"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq15.gif"></inline-graphic></alternatives></inline-formula>, cyan: <inline-formula id="IEq16"><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }} - \frac{1}{4}$$\end{document}</tex-math><mml:math id="M32"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq16.gif"></inline-graphic></alternatives></inline-formula>, green: <inline-formula id="IEq17"><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }} - \frac{1}{2}$$\end{document}</tex-math><mml:math id="M34"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq17.gif"></inline-graphic></alternatives></inline-formula>. <bold>b</bold> The f–I curves and pacemaking rhythms of the modeled cells for different Na<sup>+</sup> channel and HCN channel variants. The L5PCs are stimulated with a somatic DC of amplitude ranging from 0.25 to 1.4 nA (Hay model) or 0.7 to 0.9 nA (Almog model), and the firing frequency is plotted against the stimulus amplitude. The insets show the change in threshold current at rest in relation to that of the control neuron (0.350 nA in the Hay model, 0.418 nA in the Almog model: note that the threshold for inducing single spikes at rest is lower than the threshold for inducing continuous spiking). For SANCs, the relative difference from control cell pacemaking rhythm (4.76 Hz in the Kharche model, 2.90 Hz in the Severi model) are shown. Apart for the varied effects of Na<sup>+</sup> channel variants on L5PC f–I curves, it can observed that those variants that increase the L5PC firing frequency also mostly increase the pacemaking rhythm in SANCs, and vice versa</p></caption><graphic id="d29e1833" xlink:href="41398_2017_7_Fig1_HTML"></graphic></fig>
</p>
<p id="Par16">The results of Fig. <xref ref-type="fig" rid="Fig1">1</xref> show that the changes in Na<sup>+</sup> or HCN channels mostly caused similar effects in L5PCs and SANCs in terms of excitability. If the variant effect was excitatory (lower threshold of firing or steeper slope of f–I curve, i.e., higher gain) in L5PCs, usually the effect in SANCs was excitatory as well (faster pacemaking). We confirmed this observation by changing only one model parameter at a time (see Supplementary Fig. <xref ref-type="media" rid="MOESM1">S2</xref>). However, the effects of Na<sup>+</sup> channel variants on steady-state firing of the Hay-model neuron were usually small and often opposite to the corresponding effects in the Almog-model neuron. Exceptions to the above-mentioned trend arise also in HCN channel variants that affect both the threshold and slope of activation, leading to diverse effects in the two L5PC models (see <xref ref-type="media" rid="MOESM1">Supplementary information</xref>).</p>
</sec>
<sec id="Sec8">
<title>Pleiotropic effects of variants of Ca<sup>2+</sup> channel or transporter-encoding genes are non-analogous</title>
<p id="Par17">Next, we analyzed the implications of the genes that encode subunits of voltage-gated Ca<sup>2+</sup> channels (<italic>CACNA1C</italic>, <italic>CACNA1D</italic>, <italic>CACNB2</italic>, <italic>CACNA1I</italic>) or Ca<sup>2+</sup> transporters (<italic>ATP2A2</italic>). In Fig. <xref ref-type="fig" rid="Fig2">2</xref>, a representative set of variants of these genes is picked, and their effects on L5PC and SANC behavior is illustrated. In a similar fashion as in Fig. <xref ref-type="fig" rid="Fig1">1</xref>, Fig. <xref ref-type="fig" rid="Fig2">2a</xref> shows the time course of the membrane potential for different versions of one variant, and Fig. <xref ref-type="fig" rid="Fig2">2b</xref> shows the f–I curves and pacemaking frequencies for several variants. A general trend is that variants that increase the pacemaking rhythm in SANCs decrease the firing frequency in L5PCs, and vice versa. This is supported by Fig. <xref ref-type="fig" rid="Fig3">3</xref> showing the mean (averaged over the stimulus amplitudes of Fig. <xref ref-type="fig" rid="Fig1">1</xref>) firing frequencies of all implemented variants for the L5PC models and the corresponding pacemaking frequencies for the SANC models, and by Supplementary Figs. <xref ref-type="media" rid="MOESM1">S3</xref> and <xref ref-type="media" rid="MOESM1">S4</xref> showing results from single-parameter variants. The average firing rates and pacemaking rates of Ca<sup>2+</sup> channel and transporter variants were anticorrelated with a correlation coefficient −0.53 to −0.79, while the corresponding correlation coefficients for Na<sup>+</sup> and HCN channel variants were 0.47–0.78 (see Table <xref ref-type="table" rid="Tab2">2</xref>). Exceptions to this trend are discussed in <xref ref-type="media" rid="MOESM1">Supplementary information</xref>, and the reasons for them are illustrated in Supplementary Figs. <xref ref-type="media" rid="MOESM1">S5</xref>, <xref ref-type="media" rid="MOESM1">S6</xref>, <xref ref-type="media" rid="MOESM1">S7</xref>, and <xref ref-type="media" rid="MOESM1">S8</xref>, where the time courses of different current species are plotted for control and variant neurons.<fig id="Fig2"><label>Fig. 2</label><caption><title>Ca<sup>2+</sup> channel gene variants typically have opposite effects on L5PC firing and SANC pacemaking</title><p>
<bold>a</bold> The membrane potential time courses in control cells and cells implemented with a <italic>CACNA1C</italic> variant (the first variant in Supplementary Table <xref ref-type="media" rid="MOESM1">S2</xref>), see Fig. <xref ref-type="fig" rid="Fig1">1a</xref>. <bold>b</bold> The f–I curves and pacemaking rhythms of the modeled cells implemented with a Ca<sup>2+</sup> channel or transporter variant, see Fig. <xref ref-type="fig" rid="Fig1">1b</xref>. Apart from the <italic>CACNA1I</italic> variants that show mixed effects, it can be seen that those variants that increase the pacemaking rhythm in SANCs, decrease the L5PC firing frequency, and vice versa. Variant effects on threshold currents in L5PCs are generally small</p></caption><graphic id="d29e1971" xlink:href="41398_2017_7_Fig2_HTML"></graphic></fig>
<fig id="Fig3"><label>Fig. 3</label><caption><title>Overview of variant effects on L5PC firing and SANC pacemaking</title><p>The average firing frequencies and pacemaking rhythms are shown for all variants of Supplementary Table <xref ref-type="media" rid="MOESM1">S2</xref>. Top panel: Firing rates in the Hay model, averaged over stimulus amplitudes 0.35–1.4 nA. Second panel: Firing rates in the Almog model, averaged over stimulus amplitudes 0.7–0.9 nA. Third panel: Pacemaking rates in the Kharche model. Bottom panel: Pacemaking rates in the Severi model. See Figs. <xref ref-type="fig" rid="Fig1">1</xref> and <xref ref-type="fig" rid="Fig2">2</xref> for more detailed data. Variants shown in Figs. <xref ref-type="fig" rid="Fig1">1</xref> and <xref ref-type="fig" rid="Fig2">2</xref> are highlighted with asterisks, and variants used in combinations of Supplementary Fig. <xref ref-type="media" rid="MOESM1">S10</xref> are highlighted with crosses ('<italic> × </italic>') and circles (' ∘ ')</p></caption><graphic id="d29e2005" xlink:href="41398_2017_7_Fig3_HTML"></graphic></fig>
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Firing frequencies of L5PCs and pacemaking frequencies of SANCs are correlated for Na<sup>+</sup> channel and <italic>HCN1</italic> variants, but anticorrelated for Ca<sup>2+</sup> channel and Ca<sup>2+</sup> transporter variants</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="3">(A) Na<sup>+</sup> and HCN channel variants</th></tr><tr><th></th><th>Hay</th><th>Almog</th></tr></thead><tbody><tr><td>Kharche</td><td>0.4965</td><td>0.7477</td></tr><tr><td>Severi</td><td>0.5031</td><td>0.7818</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th colspan="3">(B) Ca<sup>2+</sup> channel and transporter variants</th></tr><tr><th></th><th>Hay</th><th>Almog</th></tr></thead><tbody><tr><td>Kharche</td><td>−0.5168</td><td>−0.5971</td></tr><tr><td>Severi</td><td>−0.7700</td><td>−0.7905</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th colspan="5">(C) All variants</th></tr><tr><th></th><th>Hay</th><th>Almog</th><th>Kharche</th><th>Severi</th></tr></thead><tbody><tr><td>Hay</td><td>1</td><td>0.6896</td><td>−0.4364</td><td>−0.7223</td></tr><tr><td>Almog</td><td>0.6896</td><td>1</td><td>−0.4233</td><td>−0.6501</td></tr><tr><td>Kharche</td><td>−0.4364</td><td>−0.4233</td><td>1</td><td>0.6645</td></tr><tr><td>Severi</td><td>−0.7223</td><td>−0.6501</td><td>0.6645</td><td>1</td></tr></tbody></table><table-wrap-foot><p>The table shows the correlation coefficients between the firing or pacemaking frequencies of <inline-formula id="IEq18"><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }} - \frac{1}{4}$$\end{document}</tex-math><mml:math id="M36"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq18.gif"></inline-graphic></alternatives></inline-formula> variants (see Fig. <xref ref-type="fig" rid="Fig3">3</xref>), as predicted by the different models. <bold>A</bold>: Only data from <italic>SCN1A</italic> and <italic>HCN1</italic> variants included. <bold>B</bold>: Only data from <italic>CACNA1C</italic>, <italic>CACNA1D</italic>, <italic>CACNB2</italic>, <italic>CACNA1I</italic> and <italic>ATP2A2</italic> variants included. <bold>C</bold>: All variants included. The variants that were not applicable for L5PC models (see the Supplementary Table <xref ref-type="media" rid="MOESM1">S2</xref> entries corresponding to studies<sup><xref ref-type="bibr" rid="CR47">47</xref>,<xref ref-type="bibr" rid="CR48">48</xref></sup>) were omitted. The relatively strong anticorrelations between L5PC and SANC model data in (C) reflect the fact that majority (80) of the variants (94 in total) operated on Ca<sup>2+</sup> channels and transporters</p></table-wrap-foot></table-wrap>
</p>
<p id="Par18">The difference in variant effects between L5PC and SANC models is caused by differences in downstream effects of the Ca<sup>2+</sup> currents. All four models describe certain aspects of how the intracellular [Ca<sup>2+</sup>], increased by the current influx through the Ca<sup>2+</sup> channels, affects the function of other transmembrane ion channels or exchangers. In the L5PC models, increased intracellular [Ca<sup>2+</sup>] activates the Ca<sup>2+</sup>-dependent K<sup>+</sup> channels, i.e., the SK channels (and BK channels in the Almog model) that are hyperpolarizing. These channels are traditionally absent from the SANC models, and while recent evidence suggests they may contribute to sinus-node electrophysiology<sup><xref ref-type="bibr" rid="CR58">58</xref>,<xref ref-type="bibr" rid="CR59">59</xref></sup>, a well-recognized characteristic of SANC function is that enhanced Ca<sup>2+</sup> cycling is an important contributor to increased pacemaking frequency both <italic>ex vivo</italic> and <italic>in vivo</italic>
<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>.</p>
</sec>
<sec id="Sec9">
<title>Changes in SANC excitability affect signal propagation</title>
<p id="Par19">We implemented a simple 1-dimensional model of interconnected SANCs to analyze the effects of the variants on signal conduction. The SANCs were identical, and were connected to each other with a diffusion constant of 6  × 10<sup>4</sup> µm<sup>2</sup>/ms (as in ref. <xref ref-type="bibr" rid="CR61">61</xref>). In this 1-dimensional model, the SANC components were first voltage-clamped to a hyperpolarized membrane potential (−64 mV), and then a fraction of them was clamped to a depolarized membrane potential ( + 23 mV), and the conduction of this pulse of activation across the SANCs could be observed. Supplementary Fig. <xref ref-type="media" rid="MOESM1">S9</xref> shows that subtle variants of Ca<sup>2+</sup> channel genes could slightly affect the signal conduction velocity along the sinoatrial node (SAN), and an overview of results for all variants is shown in Supplementary Fig. <xref ref-type="media" rid="MOESM1">S11</xref>. This propagation is altogether rapid, and, therefore, unlikely to meaningfully alter the speed or sequence of cardiac activation. However, these subtle changes may have larger effects in multiple dimensions and particularly in determining the ability of the SAN to provide sufficient current to activate the surrounding tissue. To test this hypothesis, we applied our variants in a 2-dimensional model including SAN and surrounding atrial tissue. In this experiment, we modeled the SAN tissue using the Severi model and the atrial tissue using the model of ref. <xref ref-type="bibr" rid="CR62">62</xref>. We implemented the <italic>CACNA1C</italic> variant<sup><xref ref-type="bibr" rid="CR27">27</xref></sup> (the first entry of Supplementary Table <xref ref-type="media" rid="MOESM1">S2</xref>) in the SAN tissue using the scaling threshold parameter <italic>c</italic> = 0.102. Figure <xref ref-type="fig" rid="Fig4">4</xref> shows the initiation and propagation of cardiac action potentials in this composite 2-dimensional model tissue both for control and variant cases. An interesting finding is shown in Fig. <xref ref-type="fig" rid="Fig4">4b</xref>, where the <inline-formula id="IEq19"><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }}\frac{1}{2}$$\end{document}</tex-math><mml:math id="M38"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq19.gif"></inline-graphic></alternatives></inline-formula> variant caused failure of a premature SAN beat to propagate into the atrial tissue when a large SAN (radius <italic>r</italic> = 0.4 cm) was used. This in turn resulted in an increased beat-to-beat interval, which if frequent enough, would manifest as increased R-R variability and could be clinically identified as an SAN dysfunction.<fig id="Fig4"><label>Fig. 4</label><caption><title>Signal propagation from SAN to surrounding atria is altered in a Ca<sup>2+</sup> channel variant</title><p>A tissue of size 3 × 3 cm was modeled using a diffusion constant of 1.2 cm<sup>2</sup>/s in the direction of the monitored fiber and 0.25 cm<sup>2</sup>/s in the direction orthogonal to this. A spatial resolution of 151 × 151 nodes (0.02 cm) and temporal resolution of ∆<italic>t</italic> = 0.125 ms was used. The panels show the membrane potential as a function of time at six different locations of the modeled tissue for different scalings of a <italic>CACNA1C</italic> variant (the first variant of Supplementary Table <xref ref-type="media" rid="MOESM1">S2</xref>). The center (blue) expresses membrane potential dynamics similar to that seen in single-cell experiments (Figs. <xref ref-type="fig" rid="Fig1">1</xref> and <xref ref-type="fig" rid="Fig2">2</xref>), while near the borders (magenta and yellow), the action potentials are sharper and more alike to those presented in ref.<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>. The left panels (A) show the results in a model tissue with a smaller (radius 0.27 cm) SAN, and the right panels (B) show the results using a larger (radius 0.40 cm) SAN. In the variants with smallest effect (<inline-formula id="IEq20"><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }} - \frac{1}{4}$$\end{document}</tex-math><mml:math id="M40"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq20.gif"></inline-graphic></alternatives></inline-formula> and <inline-formula id="IEq21"><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }}\frac{1}{4}$$\end{document}</tex-math><mml:math id="M42"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq21.gif"></inline-graphic></alternatives></inline-formula>), only the pacemaking frequency is altered, but in other variants, more radical phenotypes are observed. The <inline-formula id="IEq22"><alternatives><tex-math id="M43">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }} - \frac{1}{2}$$\end{document}</tex-math><mml:math id="M44"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq22.gif"></inline-graphic></alternatives></inline-formula> variant ceases pacemaking in the tissue with smaller SAN, and in the simulations with the larger SAN, all action potentials initiated by the <inline-formula id="IEq23"><alternatives><tex-math id="M45">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }}\frac{1}{2}$$\end{document}</tex-math><mml:math id="M46"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq23.gif"></inline-graphic></alternatives></inline-formula> variant SANCs are not successfully transmitted to the atrial tissue</p></caption><graphic id="d29e2501" xlink:href="41398_2017_7_Fig4_HTML"></graphic></fig>
</p>
<p id="Par20">Figure <xref ref-type="fig" rid="Fig4">4a</xref> shows that when a small SAN (radius <italic>r</italic> = 0.27 cm) was combined with the <inline-formula id="IEq24"><alternatives><tex-math id="M47">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\epsilon {\mathbf{ = }} - \frac{1}{2}$$\end{document}</tex-math><mml:math id="M48"><mml:mi>ϵ</mml:mi><mml:mi mathvariant="bold">=</mml:mi><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41398_2017_7_Article_IEq24.gif"></inline-graphic></alternatives></inline-formula> variant, spontaneous SAN activity was silenced. In this case the electrotonic load of the surrounding atrial tissue prevents the current generated by the SANCs from being sufficient to generate a propagating depolarization wave, and thus pacemaking ceases. Such a sharp loss of sinus excitation would be associated with severe (class 1) SAN dysfunction. In an intermediate-sized SAN (radius <italic>r</italic> = 0.34 cm), by contrast, all variants show a stable pacemaking (data not shown).</p>
</sec>
</sec>
<sec id="Sec10" sec-type="discussion">
<title>Discussion</title>
<p id="Par21">In this work, using computational modeling we showed how subtle genetic variants of SCZ-associated genes can cause comorbid effects in neuronal and cardiac function. We used models of L5PCs and SANCs due to the biological significance of these cells (in cortical information processing and heart beat initiation, respectively), the high level of biophysical detail with which they are described, and the similarities in expression of the genes studied here. We showed that small changes in the parameters governing the voltage-dependence and time constants of activation and inactivation of different ion channels caused observable effects in both L5PC and SANC function (Figs. <xref ref-type="fig" rid="Fig1">1</xref>–<xref ref-type="fig" rid="Fig3">3</xref>). In the case of Ca<sup>2+</sup> channel gene variants, these changes typically had opposite effects on cell excitability in L5PCs compared to SANCs (higher L5PC firing frequency ↔ lower SANC pacemaking frequency, see Fig. <xref ref-type="fig" rid="Fig2">2</xref>), while in the case of Na<sup>+</sup> or HCN channel variants, the effects were mostly similar (higher L5PC firing ↔ frequency higher SANC pacemaking frequency, see Fig. <xref ref-type="fig" rid="Fig1">1</xref>). Our framework is well suited to studying polygenic effects, which is especially important in SCZ: we showed that combinations of subtle variants of different genes can have a large effect on cell excitability (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S10</xref>). These results are, to our knowledge, the first findings from a polygenic analysis of the pleiotropic effects of genetic variants on neural and cardiac functions.</p>
<p id="Par22">Our result showing that the gain-of-function Ca<sup>2+</sup> channel variants (i.e., variants that increase Ca<sup>2+</sup> currents) increase the excitability of SANCs but decrease the excitability of L5PCs, is in line with previous studies. For SANCs, early indirect experimental evidence (e.g., in ref. <xref ref-type="bibr" rid="CR63">63</xref>) indicated that larger Ca<sup>2+</sup> currents (mediated by an increase in extracellular [Ca<sup>2+</sup>]) caused faster SAN pacemaking. More recent studies showed that a variety of manipulations that increase whole-cell Ca<sup>2+</sup> load also increase SANC pacing frequency, and that their common mechanistic link is spontaneous sarco-endoplasmic reticulum Ca<sup>2+</sup> release, which accelerates early SANC depolarization due to Na<sup>+</sup>-Ca<sup>2+</sup> exchange<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>. The source of SANC pacing is, however, still under debate<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. The contexts and molecular players determining the importance of these intracellular Ca<sup>2+</sup> fluxes remain hotly debated, but there is little doubt that gain-of-function effects in SANC Ca<sup>2+</sup> channels results in more rapid beating due either to direct depolarization or secondarily to Ca<sup>2+</sup> release from the sarco-endoplasmic reticulum.</p>
<p id="Par23">For L5PCs, there are numerous experimental studies analyzing the medium-duration after-hyperpolarization (mAHP) current, which is mediated by SK channels and is strong in L5PCs<sup><xref ref-type="bibr" rid="CR65">65</xref></sup>, but its Ca<sup>2+</sup> channel-dependent inhibitory effect on neuron firing has rarely been compared with the direct excitatory effect of the Ca<sup>2+</sup> channels. In ref. <xref ref-type="bibr" rid="CR66">66</xref>, the effect of blockade of L-type Ca<sup>2+</sup> channels on EPSP amplitude was non-significant (albeit slightly weakening the excitability) compared to control. By contrast, computational studies of L5PCs repeatedly predicted that a decrease in current through Ca<sup>2+</sup> channels increase the L5PC excitability (due to the consequent decrease in Ca<sup>2+</sup>-dependent K<sup>+</sup> current), and vice versa. In addition to the present work, this was concluded in our earlier work<sup><xref ref-type="bibr" rid="CR16">16</xref></sup> and in an independent study employing a network of L5PCs<sup><xref ref-type="bibr" rid="CR67">67</xref></sup>, where the blockade of voltage-gated Ca<sup>2+</sup> channels (especially of those located at the soma) increased the network excitability. Confirming and extending these results may require a spatially detailed neuron model and an extended description of Ca<sup>2+</sup> dynamics (cf.<sup><xref ref-type="bibr" rid="CR65">65</xref>,<xref ref-type="bibr" rid="CR68">68</xref></sup>).</p>
<p id="Par24">Apart from L5PCs, the SK-Ca<sup>2+</sup> current coupling that reverses the output gain of the Ca<sup>2+</sup> currents has been experimentally observed in other types of neurons<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>. These data could be used to validate the results obtained from our method when applied to other cell types. L5PCs are of particular interest among the types of neuron in the brain due to their role as an integrator of sensory feed-forward and cortical feed-back information<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. However, future work should address these research questions in other types of neurons as well, as made possible by the increasing availability of biophysical neuron models<sup><xref ref-type="bibr" rid="CR70">70</xref></sup>, and models of other pacemaker cells and myocytes in the heart.</p>
<p id="Par25">The differences in the levels of biophysical detail between the applied models prevent a consistent use of some of our variants. Ca<sup>2+</sup> dynamics were described in more detail in the SANC models than in the L5PC models, which reflects the known importance of Ca<sup>2+</sup> cycling in SANC function and allowed for more comprehensive analysis of SERCA (encoded by <italic>ATP2A2</italic>) variants and their effects on pacemaking. None of the models, however, takes into account nanoscale Ca<sup>2+</sup> release events, which may crucially affect the cell electrophysiology<sup><xref ref-type="bibr" rid="CR71">71</xref></sup>. The analyses of genetic effects of <italic>ATP2A2</italic> were restricted in L5PC models to one variant<sup><xref ref-type="bibr" rid="CR45">45</xref>,<xref ref-type="bibr" rid="CR46">46</xref></sup>, whose functional effects had previously been measured both in terms of SERCA uptake and cytosolic Ca<sup>2+</sup> transients. Of these quantities, the effect on SERCA uptake could be directly applied to SANC models, while the effect on cytosolic Ca<sup>2+</sup> transients could be applied to L5PC model parameters. Note, however, that the latter effect might be highly dependent on the cell type—the experiments of<sup><xref ref-type="bibr" rid="CR46">46</xref></sup> were carried out in myocytes. There is a trend toward the development of increasingly detailed biophysical neuron models and hence a L5PC model incorporating the functions of the endoplasmic reticulum (ER), SERCA pump, and relevant Ca<sup>2+</sup> signaling molecules could be expected in the near future<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>. Using such models would mitigate the above-mentioned limitation in our approach.</p>
<p id="Par26">The <italic>I</italic>
<sub><italic>f</italic></sub> current has notably different characteristics in the two SANC models. In the Kharche model, the description of the <italic>I</italic>
<sub><italic>f</italic></sub> current was formulated for <italic>HCN4</italic>-based currents, which have a very negative half-activation potential (−106.8 mV in the Kharche model) and a less steep slope (16.3 mV). By contrast, in the Severi model the <italic>I</italic>
<sub><italic>f</italic></sub> current had a much higher half-activation potential (−52.5 mV) and a steeper slope (9.0 mV). The choices concerning the <italic>I</italic>
<sub><italic>f</italic></sub> current in the Severi model are based on experiments made on rabbit SANCs where expression of both <italic>HCN1</italic> and <italic>HCN4</italic> were found<sup><xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR73">73</xref>,<xref ref-type="bibr" rid="CR74">74</xref></sup>, while the Kharche model refers to experiments made on mouse SANCs where expression of only <italic>HCN4</italic> was observed<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR75">75</xref></sup>. However, other studies found <italic>HCN1</italic> expression also in mouse SANCs<sup><xref ref-type="bibr" rid="CR76">76</xref>,<xref ref-type="bibr" rid="CR77">77</xref></sup>—<italic>HCN1</italic> is also expressed in human SANCs<sup><xref ref-type="bibr" rid="CR78">78</xref></sup>. Thus, the contribution of <italic>HCN1</italic> variants to SANC electrophysiology can be expected in both mice and humans, the latter contribution being an important assumption underlying our study.</p>
<p id="Par27">Despite the differences in the voltage-dependencies of the <italic>I</italic>
<sub><italic>f</italic></sub> current inactivation, both SANC models agree on the fact that the current is most of the time depolarizing (reversal potentials were approximately −24 mV and −4 mV in the Kharche and Severi models, respectively). Moreover, the (depolarizing) amplitude of the <italic>I</italic>
<sub><italic>f</italic></sub> current is very similar in the two models (0.006 nA in Kharche model and 0.0067 nA in the Severi model, data not shown). Accordingly, the effects of the HCN channel variants on the SANC pacemaking were qualitatively similar in the two models, as shown in Figs. <xref ref-type="fig" rid="Fig1">1</xref> and <xref ref-type="fig" rid="Fig3">3</xref>, and Supplementary Fig. <xref ref-type="media" rid="MOESM1">S2</xref> (an exception is the second-to-last variant of Fig. <xref ref-type="fig" rid="Fig3">3</xref>, whose effects on L5PC models were non-analogous as well, as discussed above).</p>
<p id="Par28">Our framework is based on downscaling the electrophysiological effects of experimentally studied genetic variants, and as a theoretical approach, it has its limitations. It is not known whether the SCZ-associated SNPs in voltage-dependent ion channel-encoding genes have a measurable effect on the voltage-dependence and kinetics of the underlying channel or not. Furthermore, the magnitudes of the variant effects depend on the conditions used for downscaling the variants, and due to the non-linearity of the neuron models, these conditions may have to be adjusted for each operated model separately to ensure that a single (downscaled) variant does not totally change any fundamental aspect of the cell functionality. Nevertheless, the downscaling framework shows promise as a tool for studying interactions of modest genetic effects, and it can be extended to new cell types and classes of genes. Another limitation of our study stems from the biophysical details that are missing from our models. Like the vast majority of the neuron and cardiac cell models of today, our models do not allow examining the effects of certain biological phenomena controlling the function of ion channels, such as phosphorylation, spatial affinity, or heterogeneous subunit compositions. Extending the models to capture some of these biophysical details would be useful especially in the study of SCZ, as the risk of SCZ has been associated with alterations in not only genes controlling intrinsic electrogenesis (voltage-gated ion channels) and neurotransmission (synaptic ion channels), but also those controlling the calcium signaling machinery affecting the two through protein phosphorylation<sup><xref ref-type="bibr" rid="CR79">79</xref></sup>. Meanwhile, novel tools in neuroinformatics, such as the automated large-scale classification of ion channel models as presented in ref. <xref ref-type="bibr" rid="CR80">80</xref>, could help in comparing the modeled effects of genetic variants between different neuron models and making predictions of the cellular functions in modified baseline conditions such as altered temperatures.</p>
<p id="Par29">Our results shed light on the correlations between neuronal and cardiac phenotypes in SCZ patients. Due to the complexity of clinical manifestations of SCZ, the neural underpinnings of the symptoms are not well understood, but there is a generic hypothesis of SCZ being a disorder of cortical excitability<sup><xref ref-type="bibr" rid="CR81">81</xref>,<xref ref-type="bibr" rid="CR82">82</xref></sup>. To this end, altered L5PC excitability has been proposed as a contributor to the observed SCZ symptoms and phenotypes, such as hallucinations<sup><xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR17">17</xref></sup>. Altered synaptic function has also been associated to SCZ (suggested both by GWASs and imaging studies), but is out of the scope of the present study. The L5PC functions studied here were restricted to responses to somatic DC—for a more detailed analysis of the effects of the variants on integration of synaptic inputs, we refer to our earlier work<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. In this work, we showed that the same subtle genetic variants that altered the L5PC excitability, also altered SANC pacemaking frequency and rate of propagation of the cardiac action potential. While these deviations are specific to pacemaker tissues in the heart, similar pleiotropic effects occurring in the ventricular myocardium could prolong the action potential or increase dispersion of repolarization, and thus be associated with the prolonged QT interval observed in drug-free SCZ patients<sup><xref ref-type="bibr" rid="CR83">83</xref></sup>. An interesting observation is that the variants may affect the probability of successful signal propagation from the SAN to the surrounding atrial tissue, as shown in Fig. <xref ref-type="fig" rid="Fig4">4b</xref>. In these simulations, the variant effects were only implemented in the sinoatrial tissue—were they present also in the atrial tissue, the observed effects on signal propagation could be larger. When this propagation failure is complete, the condition is termed third degree sinoatrial block. More subtle effects include a sporadic block that simply alters P-P variability (and therefore R-R variability) similar to that shown in Fig. <xref ref-type="fig" rid="Fig4">4b</xref>. By inducing irregular long pauses in ventricular activation, this type of behavior may contribute to the emergence of ventricular tachycardias, particularly the torsade de pointes that accompanies both acquired and congenital long QT syndrome<sup><xref ref-type="bibr" rid="CR84">84</xref>,<xref ref-type="bibr" rid="CR85">85</xref></sup>. This form of polymorphic ventricular tachycardia is also associated with the drug-induced long QT syndrome that is a major contraindication of many antipsychotic drugs<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>.</p>
<p id="Par30">Our results provide interesting views on the dual effects of SNP-like effects on neuronal and cardiac excitability. While the rare variants of ion-channel-encoding genes often have a disabling or even life-threatening phenotypic effect, the effects of common variants may be subtle and highly specific to certain types of tissue or cell type. The work at hand illustrates the polygenic effects of SCZ-associated genes by borrowing the functional genomic data from gene variants that implicate other, typically larger, phenotypic consequences, and studying the cellular functions under downscaled variant effects. These results provide an important viewpoint on the polygenic alterations of neuronal and cardiac excitability, but eventually, the electrophysiological consequences of the common, SCZ-associated SNPs should be assessed as well. Novel automated cell-patching methods<sup><xref ref-type="bibr" rid="CR86">86</xref>,<xref ref-type="bibr" rid="CR87">87</xref></sup> could help in this vast task.</p>
<p id="Par31">To conclude, the current findings support the use of a polygenic mathematical modeling approach to understand more of the pathobiology related to the GWAS-revealed SCZ-associated loci. Our results suggest overlapping but non-identical mechanisms through which subtle SNP-like variants of ion-channel and calcium-transporter-encoding genes modulate the intrinsic excitability of neurons and heart cells. This may explain some of the comorbidity between cardiac disease and SCZ, and could facilitate development of antipsychotic drugs with fewer cardiac side-effects.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Electronic supplementary material</title>
<sec id="Sec11">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41398_2017_7_MOESM1_ESM.pdf"><caption><p>Supplementary material</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>
<bold>Authors' contributions</bold>
</p>
<p>Designed the study: T.M.M., A.G.E., A.T., A.M.D., O.A.A. Provided data or analytical support: G.T.L., G.T.E. Performed the analysis: T.M.M., G.T.L. Interpreted the results: T.M.M., G.T.L., A.G.E., A.T., A.M.D., G.T.E., O.A.A. Wrote the manuscript: T.M.M., G.T.L., A.G.E., A.T., A.M.D., G.T.E., O.A.A.</p>
</fn>
</fn-group>
<sec>
<title>Supplementary information</title>
<p>The online version of this article (10.1038/s41398-017-0007-4) contains supplementary material.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>NOTUR resources were used for the simulations. Funding: NIH grant 5 R01 EB000790-10, EC-FP7 grant 604102 (“Human Brain Project”), Research Council of Norway (216699, 248778, 223273, 249711, and 248828), South East Norway Health Authority (2017-112), and KG Jebsen Stiftelsen.</p>
</ack>
<notes notes-type="COI-statement">
<sec id="FPar1">
<title>Competing interests</title>
<p>The authors declare that they have no competing financial interests.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ripke</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide association analysis identifies 13 new risk loci for schizophrenia</article-title>
<source/>Nat. Genet.
          <year>2013</year>
<volume>45</volume>
<fpage>1150</fpage>
<lpage>1159</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2742</pub-id>
<pub-id pub-id-type="pmid">23974872</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ripke</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Biological insights from 108 schizophrenia-associated genetic loci</article-title>
<source/>Nature
          <year>2014</year>
<volume>511</volume>
<fpage>421</fpage>
<lpage>427</lpage>
<pub-id pub-id-type="doi">10.1038/nature13595</pub-id>
<pub-id pub-id-type="pmid">25056061</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saha</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chant</surname>
<given-names>D</given-names>
</name>
<name>
<surname>McGrath</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time?</article-title>
<source/>Arch. Gen. Psychiatr.
          <year>2007</year>
<volume>64</volume>
<fpage>1123</fpage>
<lpage>1131</lpage>
<pub-id pub-id-type="doi">10.1001/archpsyc.64.10.1123</pub-id>
<pub-id pub-id-type="pmid">17909124</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laursen</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Munk-Olsen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Vestergaard</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Life expectancy and cardiovascular mortality in persons with schizophrenia</article-title>
<source/>Curr. Opin. Psychiatr.
          <year>2012</year>
<volume>25</volume>
<fpage>83</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1097/YCO.0b013e32835035ca</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Excess mortality of schizophrenia. A meta-analysis</article-title>
<source/>Br. J. Psychiatr.
          <year>1997</year>
<volume>171</volume>
<fpage>502</fpage>
<lpage>508</lpage>
<pub-id pub-id-type="doi">10.1192/bjp.171.6.502</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ryan</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Thakore</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Physical consequences of schizophrenia and its treatment: The metabolic syndrome</article-title>
<source/>Life Sci.
          <year>2002</year>
<volume>71</volume>
<fpage>239</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="doi">10.1016/S0024-3205(02)01646-6</pub-id>
<pub-id pub-id-type="pmid">12034344</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ray</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>KT</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>CM</given-names>
</name>
</person-group>
<article-title>Atypical antipsychotic drugs and the risk of sudden cardiac death</article-title>
<source/>N. Eng. J. Med
          <year>2009</year>
<volume>360</volume>
<fpage>225</fpage>
<lpage>235</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa0806994</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reilly</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ayis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ferrier</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients</article-title>
<source/>The Lancet
          <year>2000</year>
<volume>355</volume>
<fpage>1048</fpage>
<lpage>1052</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(00)02035-3</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glassman</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Bigger</surname>
<given-names>JT</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>Antipsychotic drugs: Prolonged QTc interval, torsade de pointes, and sudden death</article-title>
<source/>Am. J. Psychiatr.
          <year>2001</year>
<volume>158</volume>
<fpage>1774</fpage>
<lpage>1782</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.158.11.1774</pub-id>
<pub-id pub-id-type="pmid">11691681</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sotoodehnia</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction</article-title>
<source/>Nat. Genet.
          <year>2010</year>
<volume>42</volume>
<fpage>1068</fpage>
<lpage>1076</lpage>
<pub-id pub-id-type="doi">10.1038/ng.716</pub-id>
<pub-id pub-id-type="pmid">21076409</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arking</surname>
<given-names>DE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization</article-title>
<source/>Nat. Genet.
          <year>2014</year>
<volume>46</volume>
<fpage>826</fpage>
<lpage>836</lpage>
<pub-id pub-id-type="doi">10.1038/ng.3014</pub-id>
<pub-id pub-id-type="pmid">24952745</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lehnart</surname>
<given-names>SE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Leaky Ca2+release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice</article-title>
<source/>J. Clin. Invest.
          <year>2008</year>
<volume>118</volume>
<fpage>2230</fpage>
<pub-id pub-id-type="pmid">18483626</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Splawski</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations</article-title>
<source/>Proc. Natl Acad. Sci.
          <year>2005</year>
<volume>102</volume>
<fpage>8089</fpage>
<lpage>8096</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0502506102</pub-id>
<pub-id pub-id-type="pmid">15863612</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Markram</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The Human Brain Project</article-title>
<source/>Sci. Am.
          <year>2012</year>
<volume>306</volume>
<fpage>50</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="doi">10.1038/scientificamerican0612-50</pub-id>
<pub-id pub-id-type="pmid">22649994</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<mixed-citation publication-type="other">Iop L. <italic>Conference Papers in Science</italic>. Vol. 2014, p. 369246 (Hindawi Publishing Corporation, 2014).</mixed-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>M¨aki-Marttunen</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional effects of schizophrenia- linked genetic variants on intrinsic single-neuron excitability: A modeling study</article-title>
<source/>Biol. Psychiatr.: Cogn. Neurosci. Neuroimaging.
          <year>2016</year>
<volume>1</volume>
<fpage>49</fpage>
<lpage>59</lpage>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Larkum</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>A cellular mechanism for cortical associations: An organizing principle for the cerebral cortex</article-title>
<source/>Trends Neurosci.
          <year>2013</year>
<volume>36</volume>
<fpage>141</fpage>
<lpage>151</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2012.11.006</pub-id>
<pub-id pub-id-type="pmid">23273272</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hay</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schu¨rmann</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Markram</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Segev</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Models of neocortical layer 5b pyramidal cells capturing a wide range of dendritic and perisomatic active properties</article-title>
<source/>PLoS Comput. Biol.
          <year>2011</year>
<volume>7</volume>
<fpage>e1002107</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pcbi.1002107</pub-id>
<pub-id pub-id-type="pmid">21829333</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almog</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Korngreen</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>A quantitative description of dendritic conductances and its application to dendritic excitation in layer 5 pyramidal neurons</article-title>
<source/>J. Neurosci.
          <year>2014</year>
<volume>34</volume>
<fpage>182</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2896-13.2014</pub-id>
<pub-id pub-id-type="pmid">24381280</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kharche</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>A mathematical model of action potentials of mouse sinoatrial node cells with molecular bases</article-title>
<source/>Am. J. Physiol. Heart Circ. Physiol.
          <year>2011</year>
<volume>301</volume>
<fpage>H945</fpage>
<lpage>H963</lpage>
<pub-id pub-id-type="doi">10.1152/ajpheart.00143.2010</pub-id>
<pub-id pub-id-type="pmid">21724866</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Severi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fantini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Charawi</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>DiFrancesco</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>An updated computational model of rabbit sinoatrial action potential to investigate the mechanisms of heart rate modulation</article-title>
<source/>J. Physiol.
          <year>2012</year>
<volume>590</volume>
<fpage>4483</fpage>
<lpage>4499</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.2012.229435</pub-id>
<pub-id pub-id-type="pmid">22711956</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gottesman</surname>
<given-names>II</given-names>
</name>
<name>
<surname>Shields</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>A polygenic theory of schizophrenia</article-title>
<source/>Proc. Natl Acad. Sci.
          <year>1967</year>
<volume>58</volume>
<fpage>199</fpage>
<pub-id pub-id-type="doi">10.1073/pnas.58.1.199</pub-id>
<pub-id pub-id-type="pmid">5231600</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purcell</surname>
<given-names>SM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Common polygenic variation contributes to risk of schizophrenia and bipolar disorder</article-title>
<source/>Nature
          <year>2009</year>
<volume>460</volume>
<fpage>748</fpage>
<lpage>752</lpage>
<pub-id pub-id-type="pmid">19571811</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<mixed-citation publication-type="other">Sundnes J., et al. <italic>Computing the Electrical Activity in the Heart</italic>. Vol. 1 (Springer Science &amp; Business Media, 2007).</mixed-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<mixed-citation publication-type="other">Logg A., Mardal K. A., Wells G. <italic>Automated Solution of Differential Equations by the Finite Element Method: The FEniCS Book</italic>. Vol. 84. (Springer Science &amp; Business Media, 2012).</mixed-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lines</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Maleckar</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Tveito</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Mathematical models of cardiac pacemaking function</article-title>
<source/>Front. Phys.
          <year>2013</year>
<volume>1</volume>
<fpage>20</fpage>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kudrnac</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Coupled and independent contributions of residues in IS6 and IIS6 to activation gating of CaV1.2</article-title>
<source/>J. Biol. Chem.
          <year>2009</year>
<volume>284</volume>
<fpage>12276</fpage>
<lpage>12284</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M808402200</pub-id>
<pub-id pub-id-type="pmid">19265197</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Depil</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Timothy mutation disrupts the link between activation and inactivation in Cav1.2 protein</article-title>
<source/>J. Biol. Chem.
          <year>2011</year>
<volume>286</volume>
<fpage>31557</fpage>
<lpage>31564</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M111.255273</pub-id>
<pub-id pub-id-type="pmid">21685391</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hohaus</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structural determinants of L-type channel activation in segment IIS6 revealed by a retinal disorder</article-title>
<source/>J. Biol. Chem.
          <year>2005</year>
<volume>280</volume>
<fpage>38471</fpage>
<lpage>38477</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M507013200</pub-id>
<pub-id pub-id-type="pmid">16157588</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stary</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular dynamics and mutational analysis of a channelopathy mutation in the IIS6 helix of Cav1.2</article-title>
<source/>Channels
          <year>2008</year>
<volume>2</volume>
<fpage>216</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="doi">10.4161/chan.2.3.6160</pub-id>
<pub-id pub-id-type="pmid">18836301</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>ZZ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Transcript scanning reveals novel and extensive splice variations in human L-type voltage-gated calcium channel, Cav1.2 <italic>α</italic>1 subunit</article-title>
<source/>J. Biol. Chem.
          <year>2004</year>
<volume>279</volume>
<fpage>44335</fpage>
<lpage>44343</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M407023200</pub-id>
<pub-id pub-id-type="pmid">15299022</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>BZ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional characterization of alternative splicing in the C terminus of L-type CaV1. 3 channels</article-title>
<source/>J. Biol. Chem.
          <year>2011</year>
<volume>286</volume>
<fpage>42725</fpage>
<lpage>42735</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M111.265207</pub-id>
<pub-id pub-id-type="pmid">21998309</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bock</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional properties of a newly iden- tified C-terminal splice variant of Cav1.3 L-type Ca2+channels</article-title>
<source/>J. Biol. Chem.
          <year>2011</year>
<volume>286</volume>
<fpage>42736</fpage>
<lpage>42748</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M111.269951</pub-id>
<pub-id pub-id-type="pmid">21998310</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expression and roles of Cav1.3 <italic>(α</italic>1D) L-type Ca2+channel in atrioventricular node automaticity</article-title>
<source/>J. Mol. Cell. Cardiol.
          <year>2011</year>
<volume>50</volume>
<fpage>194</fpage>
<lpage>202</lpage>
<pub-id pub-id-type="doi">10.1016/j.yjmcc.2010.10.002</pub-id>
<pub-id pub-id-type="pmid">20951705</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>P´erez-Alvarez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hern´andez-Vivanco</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Caba-Gonza´lez</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Albillos</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Different roles attributed to Cav1 channel subtypes in spontaneous action potential firing and fine tuning of exocytosis in mouse chromaffin cells</article-title>
<source/>J. Neurochem.
          <year>2011</year>
<volume>116</volume>
<fpage>105</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2010.07089.x</pub-id>
<pub-id pub-id-type="pmid">21054386</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinggera</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channels</article-title>
<source/>Biol. Psychiatr.
          <year>2015</year>
<volume>77</volume>
<fpage>816</fpage>
<lpage>822</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2014.11.020</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azizan</surname>
<given-names>EA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension</article-title>
<source/>Nat. Genet.
          <year>2013</year>
<volume>45</volume>
<fpage>1055</fpage>
<lpage>1060</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2716</pub-id>
<pub-id pub-id-type="pmid">23913004</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lieb</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Scharinger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sartori</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sinnegger-Brauns</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Striessnig</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Structural determinants of CaV1. 3 L-type calcium channel gating</article-title>
<source/>Channels
          <year>2012</year>
<volume>6</volume>
<fpage>197</fpage>
<lpage>205</lpage>
<pub-id pub-id-type="doi">10.4161/chan.21002</pub-id>
<pub-id pub-id-type="pmid">22760075</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cordeiro</surname>
<given-names>JM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Accelerated inactivation of the L-type calcium current due to a mutation in CACNB2b underlies Brugada syndrome</article-title>
<source/>J. Mol. Cell. Cardiol.
          <year>2009</year>
<volume>46</volume>
<fpage>695</fpage>
<lpage>703</lpage>
<pub-id pub-id-type="doi">10.1016/j.yjmcc.2009.01.014</pub-id>
<pub-id pub-id-type="pmid">19358333</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Massa</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Yule</surname>
<given-names>DI</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Uhler</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>Comparison of fura-2 imaging and electrophysiological analysis of murine calcium channel <italic>α</italic> 1 subunits coexpressed with novel <italic>β</italic> 2 subunit isoforms</article-title>
<source/>Mol. Pharmacol.
          <year>1995</year>
<volume>47</volume>
<fpage>707</fpage>
<lpage>716</lpage>
<pub-id pub-id-type="pmid">7723731</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Link</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diversity and developmental expression of L-type calcium channel <italic>β</italic>2 proteins and their influence on calcium current in murine heart</article-title>
<source/>J. Biol. Chem.
          <year>2009</year>
<volume>284</volume>
<fpage>30129</fpage>
<lpage>30137</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M109.045583</pub-id>
<pub-id pub-id-type="pmid">19723630</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dual variation in SCN5A and CACNB2b underlies the development of cardiac conduction disease without Brugada syndrome</article-title>
<source/>Pacing Clin. Electrophysiol.
          <year>2010</year>
<volume>33</volume>
<fpage>274</fpage>
<lpage>285</lpage>
<pub-id pub-id-type="doi">10.1111/j.1540-8159.2009.02642.x</pub-id>
<pub-id pub-id-type="pmid">20025708</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murbartia´n</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Arias</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Perez-Reyes</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Functional impact of alternative splicing of human T-type Cav3.3 calcium channels</article-title>
<source/>J. Neurophysiol.
          <year>2004</year>
<volume>92</volume>
<fpage>3399</fpage>
<lpage>3407</lpage>
<pub-id pub-id-type="doi">10.1152/jn.00498.2004</pub-id>
<pub-id pub-id-type="pmid">15254077</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gomora</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Murbartian</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Arias</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Perez-Reyes</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Cloning and expression of the human T-type channel Cav3.3: insights into prepulse facilitation</article-title>
<source/>Biophys. J.
          <year>2002</year>
<volume>83</volume>
<fpage>229</fpage>
<lpage>241</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-3495(02)75164-3</pub-id>
<pub-id pub-id-type="pmid">12080115</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Periasamy</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impaired cardiac performance in heterozygous mice with a null mutation in the sarco (endo) plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene</article-title>
<source/>J. Biol. Chem.
          <year>1999</year>
<volume>274</volume>
<fpage>2556</fpage>
<lpage>2562</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.274.4.2556</pub-id>
<pub-id pub-id-type="pmid">9891028</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ji</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disruption of a single copy of the SERCA2 gene results in altered Ca2+homeostasis and cardiomyocyte function</article-title>
<source/>J. Biol. Chem.
          <year>2000</year>
<volume>275</volume>
<fpage>38073</fpage>
<lpage>38080</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M004804200</pub-id>
<pub-id pub-id-type="pmid">10970890</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dode</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dissection of the functional differences between sarco (endo) plasmic reticulum Ca2+-ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady-state and transient kinetic analyses</article-title>
<source/>J. Biol. Chem.
          <year>2003</year>
<volume>278</volume>
<fpage>47877</fpage>
<lpage>47889</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M306784200</pub-id>
<pub-id pub-id-type="pmid">12975374</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahn</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Muallem</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Multiple effects of SERCA2b mutations associated with Darier’s disease</article-title>
<source/>J. Biol. Chem.
          <year>2003</year>
<volume>278</volume>
<fpage>20795</fpage>
<lpage>20801</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M301638200</pub-id>
<pub-id pub-id-type="pmid">12670936</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cest’ele</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Self-limited hyperexcitability: Functional effect of a familial hemiplegic migraine mutation of the Nav1.1 (SCN1A) Na+channel</article-title>
<source/>J. Neurosci.
          <year>2008</year>
<volume>28</volume>
<fpage>7273</fpage>
<lpage>7283</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4453-07.2008</pub-id>
<pub-id pub-id-type="pmid">18632931</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanmolkot</surname>
<given-names>KR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The novel p.L1649Q mutation in the SCN1A epilepsy gene is associated with familial hemiplegic migraine: Genetic and functional studies</article-title>
<source/>Hum. Mutat.
          <year>2007</year>
<volume>28</volume>
<fpage>522</fpage>
<lpage>522</lpage>
<pub-id pub-id-type="doi">10.1002/humu.9486</pub-id>
<pub-id pub-id-type="pmid">17397047</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Volkers</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nav1.1 dysfunction in genetic epilepsy with febrile seizures-plus or Dravet syndrome</article-title>
<source/>Eur. J. Neurosci.
          <year>2011</year>
<volume>34</volume>
<fpage>1268</fpage>
<lpage>1275</lpage>
<pub-id pub-id-type="doi">10.1111/j.1460-9568.2011.07826.x</pub-id>
<pub-id pub-id-type="pmid">21864321</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cest’ele</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Divergent effects of the T1174S SCN1A mutation associated with seizures and hemiplegic migraine</article-title>
<source/>Epilepsia
          <year>2013</year>
<volume>54</volume>
<fpage>927</fpage>
<lpage>935</lpage>
<pub-id pub-id-type="doi">10.1111/epi.12123</pub-id>
<pub-id pub-id-type="pmid">23398611</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mantegazza</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures</article-title>
<source/>Proc. Natl Acad. Sci.
          <year>2005</year>
<volume>102</volume>
<fpage>18177</fpage>
<lpage>18182</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0506818102</pub-id>
<pub-id pub-id-type="pmid">16326807</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishii</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Nakashima</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ohmori</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Tryptophan-scanning mutagenesis in the S1 domain of mammalian HCN channel reveals residues critical for voltage-gated activation</article-title>
<source/>J. Physiol.
          <year>2007</year>
<volume>579</volume>
<fpage>291</fpage>
<lpage>301</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.2006.124297</pub-id>
<pub-id pub-id-type="pmid">17185333</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lesso</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Helical secondary structure of the external S3-S4 linker of pacemaker (HCN) channels revealed by site-dependent perturbations of activation phenotype</article-title>
<source/>J. Biol. Chem.
          <year>2003</year>
<volume>278</volume>
<fpage>22290</fpage>
<lpage>22297</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M302466200</pub-id>
<pub-id pub-id-type="pmid">12668666</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wemho¨ner</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An N-terminal deletion variant of HCN1 in the epileptic WAG/Rij strain modulates HCN current densities</article-title>
<source/>Front. Mol. Neurosci.
          <year>2015</year>
<volume>8</volume>
<fpage>63</fpage>
<pub-id pub-id-type="doi">10.3389/fnmol.2015.00063</pub-id>
<pub-id pub-id-type="pmid">26578877</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>SH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs</article-title>
<source/>Nat. Genet.
          <year>2012</year>
<volume>44</volume>
<fpage>247</fpage>
<lpage>250</lpage>
<pub-id pub-id-type="doi">10.1038/ng.1108</pub-id>
<pub-id pub-id-type="pmid">22344220</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>WT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Apamin modulates electrophysiological characteristics of the pulmonary vein and the sinoatrial node</article-title>
<source/>Eur. J. Clin. Invest.
          <year>2013</year>
<volume>43</volume>
<fpage>957</fpage>
<lpage>963</lpage>
<pub-id pub-id-type="doi">10.1111/eci.12125</pub-id>
<pub-id pub-id-type="pmid">23834267</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>MH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>BK channels regulate sinoatrial node firing rate and cardiac pacing in vivo</article-title>
<source/>Am. J. Physiol. Heart Circ. Physiol.
          <year>2014</year>
<volume>307</volume>
<fpage>H1327</fpage>
<lpage>H1338</lpage>
<pub-id pub-id-type="doi">10.1152/ajpheart.00354.2014</pub-id>
<pub-id pub-id-type="pmid">25172903</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lakatta</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Maltsev</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Vinogradova</surname>
<given-names>TM</given-names>
</name>
</person-group>
<article-title>A coupled system of intracellular Ca2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart’s pacemaker</article-title>
<source/>Circ. Res.
          <year>2010</year>
<volume>106</volume>
<fpage>659</fpage>
<lpage>673</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.206078</pub-id>
<pub-id pub-id-type="pmid">20203315</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mathematical models of action potentials in the periphery and center of the rabbit sinoatrial node</article-title>
<source/>Am. J. Physiol. Heart Circ. Physiol.
          <year>2000</year>
<volume>279</volume>
<fpage>H397</fpage>
<lpage>H421</lpage>
<pub-id pub-id-type="pmid">10899081</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koivuma¨ki</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Korhonen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tavi</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Impact of sarcoplasmic reticulum calcium release on calcium dynamics and action potential morphology in human atrial myocytes: a computational study</article-title>
<source/>PLoS Comput. Biol.
          <year>2011</year>
<volume>7</volume>
<fpage>e1001067</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pcbi.1001067</pub-id>
<pub-id pub-id-type="pmid">21298076</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seifen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Schaer</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Effect of calcium on the membrane potentials of single pacemaker fibres and atrial fibres in isolated rabbit atria</article-title>
<source/>Nature
          <year>1964</year>
<volume>202</volume>
<fpage>1223</fpage>
<lpage>1224</lpage>
<pub-id pub-id-type="doi">10.1038/2021223a0</pub-id>
<pub-id pub-id-type="pmid">14217522</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lakatta</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>DiFrancesco</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>What keeps us ticking, a funny current, a calcium clock, or both?</article-title>
<source/>J. Mol. Cell. Cardiol.
          <year>2009</year>
<volume>47</volume>
<fpage>157</fpage>
<pub-id pub-id-type="doi">10.1016/j.yjmcc.2009.03.022</pub-id>
<pub-id pub-id-type="pmid">19361514</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stocker</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Ca2+-activated K+channels: Molecular determinants and function of the SK family</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2004</year>
<volume>5</volume>
<fpage>758</fpage>
<lpage>770</lpage>
<pub-id pub-id-type="doi">10.1038/nrn1516</pub-id>
<pub-id pub-id-type="pmid">15378036</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faber</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Functional interplay between NMDA receptors, SK channels and voltage-gated Ca2+channels regulates synaptic excitability in the medial prefrontal cortex</article-title>
<source/>J. Physiol.
          <year>2010</year>
<volume>588</volume>
<fpage>1281</fpage>
<lpage>1292</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.2009.185645</pub-id>
<pub-id pub-id-type="pmid">20194128</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papoutsi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sidiropoulou</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cutsuridis</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Poirazi</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Induction and modulation of persistent activity in a layer V PFC microcircuit model</article-title>
<source/>Front. Neural Circuits
          <year>2013</year>
<volume>7</volume>
<fpage>161</fpage>
<pub-id pub-id-type="doi">10.3389/fncir.2013.00161</pub-id>
<pub-id pub-id-type="pmid">24130519</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Stuart</surname>
<given-names>GJ</given-names>
</name>
</person-group>
<article-title>Different calcium sources control somatic versus dendritic SK channel activation during action potentials</article-title>
<source/>J. Neurosci.
          <year>2013</year>
<volume>33</volume>
<fpage>19396</fpage>
<lpage>19405</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2073-13.2013</pub-id>
<pub-id pub-id-type="pmid">24336706</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simms</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Zamponi</surname>
<given-names>GW</given-names>
</name>
</person-group>
<article-title>Neuronal voltage-gated calcium channels: Structure, function, and dysfunction</article-title>
<source/>Neuron
          <year>2014</year>
<volume>82</volume>
<fpage>24</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2014.03.016</pub-id>
<pub-id pub-id-type="pmid">24698266</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Markram</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reconstruction and simulation of neocortical microcircuitry</article-title>
<source/>Cell
          <year>2015</year>
<volume>163</volume>
<fpage>456</fpage>
<lpage>492</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2015.09.029</pub-id>
<pub-id pub-id-type="pmid">26451489</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macquaide</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ryanodine receptor cluster fragmentation and redistribution in persistent atrial fibrillation enhance calcium release</article-title>
<source/>Cardiovasc. Res.
          <year>2015</year>
<volume>108</volume>
<fpage>387</fpage>
<lpage>398</lpage>
<pub-id pub-id-type="doi">10.1093/cvr/cvv231</pub-id>
<pub-id pub-id-type="pmid">26490742</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blackwell</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Approaches and tools for modeling signaling pathways and calcium dynamics in neurons</article-title>
<source/>J. Neurosci. Methods
          <year>2013</year>
<volume>220</volume>
<fpage>131</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="doi">10.1016/j.jneumeth.2013.05.008</pub-id>
<pub-id pub-id-type="pmid">23743449</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Altomare</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Heteromeric HCN1–HCN4 channels: a comparison with native pacemaker channels from the rabbit sinoatrial node</article-title>
<source/>J. Physiol.
          <year>2003</year>
<volume>549</volume>
<fpage>347</fpage>
<lpage>359</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.2002.027698</pub-id>
<pub-id pub-id-type="pmid">12702747</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barbuti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Baruscotti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Difrancesco</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>The pacemaker current: from basics to the clinics</article-title>
<source/>J. Cardiovasc. Electrophysiol.
          <year>2007</year>
<volume>18</volume>
<fpage>342</fpage>
<lpage>347</lpage>
<pub-id pub-id-type="doi">10.1111/j.1540-8167.2006.00736.x</pub-id>
<pub-id pub-id-type="pmid">17284289</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dobrzynski</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yanni</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Boyett</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Organisation of the mouse sinoatrial node: structure and expression of HCN channels</article-title>
<source/>Cardiovasc. Res.
          <year>2007</year>
<volume>73</volume>
<fpage>729</fpage>
<lpage>738</lpage>
<pub-id pub-id-type="doi">10.1016/j.cardiores.2006.11.016</pub-id>
<pub-id pub-id-type="pmid">17222809</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moosmang</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cellular expression and functional characterization of four hyperpolarization-activated pacemaker channels in cardiac and neuronal tissues</article-title>
<source/>Eur. J. Biochem.
          <year>2001</year>
<volume>268</volume>
<fpage>1646</fpage>
<lpage>1652</lpage>
<pub-id pub-id-type="doi">10.1046/j.1432-1327.2001.02036.x</pub-id>
<pub-id pub-id-type="pmid">11248683</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marionneau</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart</article-title>
<source/>J. Physiol.
          <year>2005</year>
<volume>562</volume>
<fpage>223</fpage>
<lpage>234</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.2004.074047</pub-id>
<pub-id pub-id-type="pmid">15498808</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular mapping of sinoatrial node HCN channel expression in the human heart</article-title>
<source/>Circ. Arrhythm. Electrophysiol.
          <year>2015</year>
<volume>8</volume>
<fpage>1219</fpage>
<lpage>1227</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCEP.115.003070</pub-id>
<pub-id pub-id-type="pmid">26304511</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devor</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia</article-title>
<source/>Mol. Psychiatr.
          <year>2017</year>
<volume>22</volume>
<fpage>792</fpage>
<lpage>801</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2017.33</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Podlaski</surname>
<given-names>WF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mapping the function of neuronal ion channels in model and experiment</article-title>
<source/>eLife
          <year>2017</year>
<volume>6</volume>
<fpage>e22152</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.22152</pub-id>
<pub-id pub-id-type="pmid">28267430</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<mixed-citation publication-type="other">O’Donnell P. <italic>Cortical Deficits In Schizophrenia,</italic> p. 219–236 (Springer, 2008).</mixed-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Falkai</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wobrock</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Transcranial brain stimulation in schizophrenia: Targeting cortical excitability, connectivity and plasticity</article-title>
<source/>Curr. Med. Chem.
          <year>2013</year>
<volume>20</volume>
<fpage>405</fpage>
<lpage>413</lpage>
<pub-id pub-id-type="pmid">23157633</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujii</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>QT is longer in drug-free patients with schizophrenia compared with age-matched healthy subjects</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<fpage>e98555</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0098555</pub-id>
<pub-id pub-id-type="pmid">24887423</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Viskin</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mode of onset of torsade de pointes in congenital long QT syndrome</article-title>
<source/>J. Am. Coll. Cardiol.
          <year>1996</year>
<volume>28</volume>
<fpage>1262</fpage>
<lpage>1268</lpage>
<pub-id pub-id-type="doi">10.1016/S0735-1097(96)00311-7</pub-id>
<pub-id pub-id-type="pmid">8890825</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Viskin</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Arrhythmias in the congenital long QT syndrome: How often is torsade de pointes pause dependent?</article-title>
<source/>Heart
          <year>2000</year>
<volume>83</volume>
<fpage>661</fpage>
<lpage>666</lpage>
<pub-id pub-id-type="doi">10.1136/heart.83.6.661</pub-id>
<pub-id pub-id-type="pmid">10814624</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<mixed-citation publication-type="other">Ranjan R., et al. <italic>Automated Biophysical Characterization of the Complete Rat Kv-ion Channel Family</italic>, 2014. Society for Neuroscience Meeting (SfN 2014), Washington, DC, USA. November 15–19, 2014.</mixed-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kodandaramaiah</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Franzesi</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Chow</surname>
<given-names>BY</given-names>
</name>
<name>
<surname>Boyden</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Forest</surname>
<given-names>CR</given-names>
</name>
</person-group>
<article-title>Automated whole-cell patch-clamp electrophys- iology of neurons in vivo</article-title>
<source/>Nat. Methods
          <year>2012</year>
<volume>9</volume>
<fpage>585</fpage>
<lpage>587</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth.1993</pub-id>
<pub-id pub-id-type="pmid">22561988</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>